A single destination for timely, editor-curated robotics news from around the world.
Enovis Corp. has announced a binding offer to acquire eCential Robotics for approximately €155 million, exceeding $180 million. This acquisition aims to integrate eCential's modular surgical robotics platform into Enovis' ASTRA technology platform, enhancing its capabilities in orthopedic surgery. The addition of eCential's robotic technology is significant as it aligns with Enovis' strategy to provide surgeons with diverse technological options. CEO Damien McDonald emphasized that this move will strengthen their market position and expand strategic opportunities in robotic-assisted surgery, addressing evolving market demands. Looking ahead, Enovis plans to finalize the acquisition by the end of 2026, with an initial payment of €176 million and potential additional payments based on performance milestones. The integration of eCential's expertise is expected to accelerate the development of next-generation robotic solutions, particularly in knee and shoulder surgeries, within the next two years.
RoboticsBusinessReview.com By Brianna Wessling Sep 05, 2026 Financial Healthcare Robotics Markets / Industries Mergers & Acquisitions News Robots / Platforms
During the July 23 episode of Mad Money, Jim Cramer emphasized a significant shift in investor sentiment towards Johnson & Johnson (NYSE:JNJ) following the FDA's approval of its OTTAVA Robotic Surgical System. This approval is seen as a pivotal moment that positions JNJ as a key player in the high-tech healthcare sector, despite initial market skepticism after a strong earnings report. Cramer's advocacy for JNJ underscores the importance of high-quality defensive stocks in a diversified portfolio, especially during volatile market conditions. The FDA's De Novo marketing authorization for the OTTAVA system marks a major milestone, enabling a range of surgical procedures and allowing JNJ to leverage its extensive hospital network for market penetration. Looking ahead, JNJ plans a targeted rollout of the OTTAVA system in select U.S. hospitals while pursuing international approvals and additional clinical trials. The company's entry into the soft-tissue robotics market positions it to compete with established players like Intuitive Surgical, potentially capturing market share while maintaining a conservative valuation. No further timeline was disclosed at the time of publication.
YahooFinance Aug 03, 2026
Recently, a medical team in China completed the world's first AI ultrasound robot-assisted interventional procedure for congenital heart disease. Conducted by the Cardiovascular Medicine Department of the Sixth Medical Center of the PLA General Hospital, this surgery marks a significant milestone in the clinical application of intelligent technology in healthcare. This breakthrough is crucial as it signifies the integration of artificial intelligence into one of the most critical aspects of surgical procedures: interpreting images, assessing positions, and aiding doctors in formulating operational plans. Traditionally, cardiovascular interventions heavily relied on physician experience, particularly in complex cases where accurate understanding of heart structure changes is essential. Looking ahead, the focus may shift from merely achieving higher precision with robotic arms to whether robots can comprehend medical images, analyze patient conditions, and adapt strategies in real-time. The integration of AI models, medical imaging, and robotic control systems will be vital for advancing surgical capabilities, especially in areas lacking experienced specialists.
leaderobot.com By Leaderobot Sep 08, 2026 AI in Healthcare Surgical Robotics Medical Imaging Cardiovascular Surgery
Medtronic PLC has announced a strategic partnership with Cornerstone Robotics Ltd., which includes a significant investment of $700 million. This collaboration grants Medtronic distribution rights for Cornerstone's Sentire surgical system in select international markets, enhancing its portfolio alongside the existing Hugo robotic-assisted surgery system. This partnership is crucial as it aims to expand access to robotic-assisted surgery, addressing the diverse needs of surgeons and healthcare systems. Medtronic's senior vice president, Matt Anderson, emphasized the importance of investing in multiple robotic platforms and digital tools to drive the next generation of minimally invasive surgery, a key growth area for the company. Looking ahead, the collaboration is expected to enhance Medtronic's offerings in the surgical ecosystem, providing a dual-platform solution that meets various clinical and operational requirements. No further timeline was disclosed at the time of publication.
RoboticsBusinessReview.com By The Robot Report Staff Sep 03, 2026 Financial Healthcare Robotics Investments Markets / Industries News Robots / Platforms
Enovis announced its acquisition of eCential Robotics for €155 million (approximately $180 million) to advance the development of surgical robots for orthopedic procedures. This strategic move aims to close a competitive gap and formalize an existing collaboration with eCential, which previously developed Johnson & Johnson's Velys Spine surgical robot. Enovis plans to launch a knee robot in late 2028 and a shoulder robot in 2029, enhancing its Astra enabling technology system with robotics capabilities. The acquisition is significant as it positions Enovis to compete more effectively in the orthopedic surgical robot market, where rivals like Johnson & Johnson and Stryker are already active. Enovis CEO Damien McDonald emphasized that integrating robotics technology is crucial for the company's long-term growth strategy. The planned knee and shoulder robots are expected to feature unique capabilities, including a robotic arm with seven degrees of freedom, setting them apart from existing offerings in the market. Looking ahead, Enovis aims to leverage eCential's expertise to accelerate product development and respond more effectively to clinician needs. The acquisition includes an upfront payment and potential milestone payments totaling up to €35 million, contingent on the successful development of the new devices. No further timeline was disclosed at the time of publication.
YahooFinance Sep 02, 2026
In June 2026, a significant medical technology milestone was achieved as a Chinese medical team, in collaboration with research institutions, successfully performed the world's first ultra-remote minimally invasive surgery using '5G + Embodied AI'. This operation demonstrated ultra-low latency control over thousands of kilometers, providing real-time feedback on tissue tension and vascular resistance to the remote surgeon. This advancement signifies a shift in surgical robotics from traditional remote manipulation tools to systems that incorporate physical AI autonomy and enhanced human-machine integration. The lead surgeon emphasized that the tactile feedback from the control console was crucial for performing the surgery, highlighting the importance of sensory perception in robotic-assisted procedures. Future developments will focus on overcoming the engineering challenges associated with achieving micro-level tactile feedback and stability in robotic systems. No further timeline was disclosed at the time of publication.
leaderobot.com By Leaderobot Jul 27, 2026 Surgical Robotics Embodied AI Minimally Invasive Surgery Tactile Feedback Medical Technology
Investors in Vicarious Surgical have voted to shut down and liquidate the surgical robotics company immediately. CEO Stephen From, who joined in 2025, expressed frustration over the company's inability to reach a design freeze for its R&D program by the end of 2026, despite raising approximately $300 million since its inception. The decision to liquidate comes after the company's market capitalization fell significantly, leading to its inclusion on the NYSE watch list for potential delisting. Vicarious Surgical's board cited ongoing operating losses and negative cash flows as reasons for the closure, with nearly $3.7 million in cash reported as of March 31, indicating insufficient funds to continue operations. Looking ahead, Vicarious Surgical's assets will be auctioned off to settle outstanding obligations, and an assignee will oversee the liquidation process. The company reported total liabilities of $9 million and assets of $12.6 million, with significant losses in recent quarters, raising concerns about the future of its technology and potential buyers.
RoboticsBusinessReview.com By Jim Hammerand Jul 21, 2026 Financial Healthcare Robotics Markets / Industries News Vicarious Surgical
Noah Medical, a surgical robotics firm backed by SoftBank, is preparing to file for a Hong Kong listing as early as next year. The company aims to raise over $100 million to bolster its expansion efforts in mainland China. Founder Zhang Jian emphasized that Hong Kong's status as an international financial center makes it an ideal location for their listing. The move is significant as Noah Medical seeks to tap into the growing demand for surgical robotics in China. With regulatory approval from China's drug regulator obtained in November, the company is targeting hospitals such as Sir Run Run Shaw Hospital for its products. Currently, 90% of Noah Medical's revenue comes from the U.S., where its surgical robots have successfully treated around 15,000 patients. Looking ahead, the company’s listing could provide the necessary capital to enhance its market presence in China. No further timeline was disclosed at the time of publication.
SCMPTech By Julie Zhang Aug 28, 2026
Harmonic Drive has unveiled its latest innovation, the LPA 20 integrated servo actuator, enhancing its reputation as a leading supplier of motion control components for surgical robotics. This new actuator is designed to provide exceptional precision and a compact form factor, addressing significant challenges faced by original equipment manufacturers (OEMs) in the medical field. The launch underscores Harmonic Drive's commitment to advancing technology in surgical applications, ensuring that OEMs can meet the growing demands for efficiency and reliability in robotic systems.
RoboticsTomorrow.com Jul 06, 2026
At the 2026 Hamlin Medical Robotics Symposium held in London, Li Aili, chairperson of Yuanhua Intelligent, unveiled the Kuntuo® orthopedic robot, which has successfully been utilized in over 7,000 surgeries. The robot's innovative open system architecture distinguishes it from competitors by enabling compatibility with a wide range of local prosthetics. This feature not only enhances its market potential in Brazil but also provides valuable insights for the advancement of orthopedic robotics on a global scale.
leaderobot.com By Leaderobot Jun 30, 2026 Surgical Robotics Orthopedic Surgery Medical Technology International Collaboration
Surgical Robotics Technology announced the winners of the Surgical Robotics Industry Awards 2026 today, highlighting outstanding achievements in the field. The awards celebrate the significant contributions made by individuals, organizations, and innovative technologies that have advanced the surgical robotics sector. This annual event aims to acknowledge excellence and inspire further advancements within the industry, showcasing the vital role of robotics in enhancing surgical procedures. The recognition serves to motivate professionals and organizations to continue pushing the boundaries of technology in healthcare.
AZOrobotics.com Jun 24, 2026RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.